Mira Pharmaceuticals (MIRA) Assets Average (2023 - 2025)

Mira Pharmaceuticals has reported Assets Average for 3 years, with the latest figure at $9.4 million in Q4 2025.

• Quarterly Assets Average rose 160.47% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (up 160.47% YoY) and the FY2025 annual result came in at $7.0 million, up 78.43% from the prior year.
• Assets Average advanced to $9.4 million in Q4 2025 per MIRA's latest filing, from $4.3 million in the prior quarter.
• Over five years, Assets Average peaked at $9.4 million in Q4 2025 and troughed at $1.1 million in Q2 2025.
• A 3-year average of $4.8 million and a median of $4.3 million in 2024 frame the typical range for Assets Average.
• The widest YoY moves for Assets Average: up 160.47% in 2025, down 50.54% in 2025.
• Over 3 years, Assets Average stood at $7.0 million in 2023, then plunged by 48.46% to $3.6 million in 2024, then jumped by 160.47% to $9.4 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $9.4 million, $4.3 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.